catalog number :
MBS2085915
products full name :
Monoclonal Antibody to Transforming Growth Factor Beta 3 (TGFb3)
products short name :
[Transforming Growth Factor Beta 3 (TGFb3)]
products name syn :
[TGF-B3; LAP; Latency-associated peptide]
other names :
[transforming growth factor beta-3 isoform 2; Transforming growth factor beta-3; transforming growth factor beta-3; transforming growth factor beta 3]
products gene name :
[TGFb3]
other gene names :
[TGFB3; TGFB3; ARVD; LDS5; RNHF; ARVD1; TGF-beta3; TGF-beta-3; LAP]
purity :
Protein A + Protein G affinity chromatography
form :
Supplied as solution form in 0.01M PBS, pH7.4, containing 0.05% Proclin-300,50% glycerol.
storage stability :
Storage: Avoid repeated freeze/thaw cycles. Store at 4ºC for frequent use. Aliquot and store at -20ºC for 12 months. Stability Test: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
tested application :
WB; IHC; ICC; IP.
app notes :
Western blotting: 0.5-2 Ug/mL;1:500-2000. Immunohistochemistry: 5-20 Ug/mL;1:50-200. Immunocytochemistry: 5-20 Ug/mL;1:50-200. Optimal working dilutions must be determined by end user.
image1 heading :
Western Blot (WB)
image2 heading :
Western Blot (WB)
image3 heading :
Immunohistochemistry (IHC)
other info1 :
Organism Species: Homo sapiens (Human). Source: Monoclonal antibody preparation. Traits: Liquid. Immunogen: Recombinant TGFb3 (Leu24~Arg300) expressed in E.coli
ncbi acc num :
NP_001316867.1
ncbi gb acc num :
NM_001329938.1
ncbi pathways :
AGE-RAGE Signaling Pathway In Diabetic Complications (1319988); AGE-RAGE Signaling Pathway In Diabetic Complications (1319775); ALK1 Signaling Events Pathway (137968); Amoebiasis Pathway (167324); Amoebiasis Pathway (167191); Cell Cycle Pathway (83054); Cell Cycle Pathway (463); Chagas Disease (American Trypanosomiasis) Pathway (147809); Chagas Disease (American Trypanosomiasis) Pathway (147795); Chronic Myeloid Leukemia Pathway (83116)
ncbi summary :
This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. This protein is involved in embryogenesis and cell differentiation, and may play a role in wound healing. Mutations in this gene are a cause of aortic aneurysms and dissections, as well as familial arrhythmogenic right ventricular dysplasia 1. [provided by RefSeq, Aug 2016]
uniprot summary :
TGFB3: Involved in embryogenesis and cell differentiation. Homodimer; disulfide-linked. Interacts with ASPN. Belongs to the TGF-beta family. Protein type: Cell development/differentiation; Ligand, receptor tyrosine kinase; Motility/polarity/chemotaxis; Secreted; Secreted, signal peptide. Chromosomal Location of Human Ortholog: 14q24.3. Cellular Component: cell soma; cell surface; extracellular matrix; extracellular region; extracellular space; intracellular membrane-bound organelle; nucleus; plasma membrane; T-tubule. Molecular Function: cytokine activity; growth factor activity; identical protein binding; protein binding; protein heterodimerization activity; transforming growth factor beta binding; type II transforming growth factor beta receptor binding. Biological Process: activation of MAPK activity; aging; alveolus development; BMP signaling pathway; cell development; cell growth; cell-cell junction organization; embryonic neurocranium morphogenesis; female pregnancy; gut development; in utero embryonic development; inner ear development; mammary gland development; negative regulation of cell proliferation; negative regulation of DNA replication; negative regulation of neuron apoptosis; negative regulation of transforming growth factor beta receptor signaling pathway; odontogenesis; palate development; platelet degranulation; positive regulation of apoptosis; positive regulation of bone mineralization; positive regulation of cell division; positive regulation of collagen biosynthetic process; positive regulation of DNA replication; positive regulation of filopodium formation; positive regulation of protein secretion; positive regulation of stress fiber formation; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-templated; regulation of apoptosis; regulation of MAPK cascade; response to estrogen; response to hypoxia; response to progesterone; salivary gland morphogenesis; transforming growth factor beta receptor signaling pathway; uterine wall breakdown; wound healing. Disease: Arrhythmogenic Right Ventricular Dysplasia, Familial, 1; Rienhoff Syndrome